Autologous Adipose Cells Therapy

Part of paid clinical trials in Lewes, Delaware.

Sponsor
CERM INC.
Study ID
NCT06869252
Phase
PHASE1/PHASE2
Status
Recruiting

Conditions

  • Fine Lines
  • Hair Loss/Baldness
  • Hair Thinning
  • Skin Elasticity
  • Skin Pigmentation
  • Skin Texture
  • Volume
  • Wrinkle Appearance

Eligibility Criteria

Sex
ALL
Age
21 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

  • Autologous Adipose Cells Therapy — BIOLOGICAL
    Participants will receive Autologous Adipose Cells therapy treatment, and the safety and efficacy of the treatment will be monitored by the primary investigator up to 25 weeks.

Study Details

Autologous Adipose Cell Therapy is a series of process designated to address the demerits of the traditional autologous fat grafting and dermal fillers, while enhancing the versatility and aesthetic outcomes. In this study, the goal is to evaluate the safety and efficacy of Autologous Adipose cell Therapy for skin rejuvenation and hair improvement in human application.

Key Dates

Start date
Aug 1, 2025
Status verified
May 2025
Primary completion
Nov 1, 2025
Completion
Feb 1, 2026

Study Design

Enrollment
40 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Autologous Adipose Cells Therapy

Primary Outcome Measure

Outcome Comparison Survey [ Time Frame: The end of the study (Week 20 to 25) ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
The Centre for Cosmetic Surgery & Medicine, NewarkLewesDelaware19958
Dr. Abdollah M. Malekzadeh, MD
302-645-7672
The Centre for Cosmetic Surgery & MedicineNewarkDelaware19713
Dr. Abdollah M. Malekzadeh, MD
302-994-8492

Find similar trials in Lewes, DE

Related Studies